Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children

Virology Journal

Volumn 9, Issue , 2012, Pages

  Esposito, Susanna ^a   Molteni, Claudio Giuseppe ^a   Giliani, Silvia ^b   Mazza, Cinzia ^b   Scala, Alessia ^a   Tagliaferri, Laura ^a   Pelucchi, Claudio ^c   Fossali, Emilio ^d   Plebani, Alessandro ^b   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Children; Influenza; Innate immunity; Pandemic A H1N1 2009 influenza virus; TLR3; Toll like receptors

Indexed keywords

GENOMIC DNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD;

CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 3;

ORTHOMYXOVIRIDAE;

EID: 84868706529     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-270     Document Type: Article

References (38)

1. Pathogen recognition and innate immunity. Akira S, Uematsu S, Takeuchi O, Cell 2006 124 783 801 10.1016/j.cell.2006.02.015 16497588 (Pubitemid 43261452)
2. Innate immune recognition of viral infection. Kawai T, Akira S, Nat Immunol 2006 7 131 137 16424890 (Pubitemid 43135878)
3. Innate immune recognition of nucleic acids. Xiao T, Immunol Res 2009 43 98 108 10.1007/s12026-008-8053-x 18810334
4. The battle between virus and host modulation of toll-like receptors signaling pathway by virus infection. Yokota S, Okabayashi T, Fujii N, Mediators Inflamm 2010 2010 184328 20672047
5. Recent insights into the role of toll-like receptors in viral infections. Carty M, Bowie AG, Clin Exp Immunol 2010 161 397 406 10.1111/j.1365-2249.2010. 04196.x 20560984
6. Pathogen recognition by innate receptors. Kamugai Y, Takeuchi O, Akira S, J Infect Chemother 2008 14 86 92 10.1007/s10156-008-0596-1 18622669 (Pubitemid 351624472)
7. Innate recognition of viruses. Pichlmair A, Reis E, Sousa C, Immunity 2007 25 419 441
8. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A, Science 2007 315 1398 1401 10.1126/science.1136880 17272685 (Pubitemid 46399546)
9. TLR3 deficiency in patients with herpes simplex encephalitis. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL, Science 2007 317 1522 1527 10.1126/science.1139522 17872438 (Pubitemid 47417427)
10. The dsRNA binding site of human toll-like receptor 3. Bell JK, Askins J, Hall PR, Davies DR, Segal DM, Proc Natl Acad Sci USA 2006 103 8792 8797 10.1073/pnas.0603245103 16720699 (Pubitemid 43878098)
11. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. Ishizaki Y, Takemoto M, Kira R, Kusuhara K, Torisu H, Sanefuji M, Yukaya N, Hara T, J Neurovirol 2008 14 486 491 10.1080/13550280802298120 19016379
12. Polymorphisms in TLR4 and TLR9 influence viral load in a sero-incident cohort of HIV-1 infected individuals. Pine SO, McElrath MJ, Bochud PY, AIDS 2009 23 2387 2395 10.1097/QAD.0b013e328330b489 19855253
13. Association between common toll-like receptor4 mutations and severe respiratory syncytial virus disease. Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, Oron A, Itskovich S, Ballin A, Houri S, Beigelman A, Lider O, Rechavi G, Amariglio N, J Infect Dis 2004 189 2057 2063 10.1086/420830 15143473 (Pubitemid 38692286)
14. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Szein MB, Hemming VG, Blanco JC, Vogel SN, J Immunol 2007 179 3171 3177 17709532
15. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double stranded RNA and influenza A viruses. Guillot L, Goffic R, Bloch S, Escriou N, Akia S, Si-Tahar M, J Biol Chem 2005 280 5571 5580 15579900 (Pubitemid 40280035)
16. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signaling. Geeraedts F, Goutagny N, Hornung V, Severa M, de Haan A, Pool J, Wilschut J, Fitzgerald KA, Huckriede A, PLoS Pathog 2008 4 1000138 10.1371/journal.ppat.1000138 18769719
17. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Hidaka F, Matsuo S, Muta T, Takeshige K, Mizukami T, Nunoi H, Clin Immunol 2006 119 188 194 10.1016/j.clim.2006.01.005 16517210
18. Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. Al-Qahtani A, Al-Ahdal M, Abdo A, Sanai F, Al-Anazi M, Khalaf N, Viswan NA, Al-Ashgar H, Al-Humaidan H, Al-Suwayeh R, Hussain Z, Alarifi S, Al-Okail M, Almajhdi FN, J Med Virol 2012 84 1353 1359 10.1002/jmv.23271 22825813
19. World Health Organization, DG statement following the meeting of the Emergency Committee 2009 http://www.who.int/csr/disease/swineflu/4th-meeting- ihr/en/print.html
20. Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy. Esposito S, Marchese A, Tozzi AE, Rossi GA, Da Dalt L, Bona G, Pelucchi C, Schito GC, Principi N, Italian Pneumococcal CAP Group, Pediatr Infect Dis J 2012 31 705 710 10.1097/INF.0b013e31825384ae 22426300
21. Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Martin ET, Kuypers J, Wald A, Englund JA, Influenza Other Respir Viruses 2012 6 71 77 10.1111/j.1750-2659. 2011.00265.x
22. Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus. Martin ET, Kuypers J, Heugel J, Englund JA, Diagn Microbiol Infect Dis 2008 62 382 388 10.1016/j.diagmicrobio. 2008.08.002 18842376
23. TLR pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Shinya K, Okamura T, Sueta S, Kasai N, Tanaka M, Ginting TE, Makino A, Eisfeld AJ, Kawaoka Y, Virol J 2011 8 97 10.1186/1743-422X-8-97 21375734
24. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Wong JP, Christopher ME, Viswanathan S, Karpoff N, Dai X, Das D, Sun LQ, Wang M, Salazar AM, Vaccine 2009 7 3481 3483
25. Augmented lung inflammation protects against influenza A pneumonia. Tuvim MJ, Evans SE, Clement CG, Dickey BF, Gilbert BE, PLoS One 2009 4 4176 10.1371/journal.pone.0004176 19137067
26. Detrimental contribution of the toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M, PLoS Pathog 2006 2 53 10.1371/journal.ppat.0020053 16789835 (Pubitemid 43998849)
27. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S, Br J Opthalmol 2007 91 962 965 10.1136/bjo.2006.113449 (Pubitemid 47013114)
28. Toll-like receptor 3 associates with c-SRC tyrosine kinase on endosomes to initiate antiviral signaling. Johnsen IB, Nguyen TT, Ringdal M, Tryggestad AM, Bakke O, Lien E, Espevik T, Anthonsen MW, EMBO J 2006 25 3335 3346 10.1038/sj.emboj.7601222 16858407 (Pubitemid 44141791)
29. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T, Esterhuizen TM, Tissue Antigens 2005 66 125 130 10.1111/j.1399-0039.2005.00454.x 16029432 (Pubitemid 41025934)
30. Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvant. Ainai A, Tashiro M, Hasegawa H, Hum Vaccin 2011 7 Suppl 174 182 21321485
31. Comparison of nasopharyngeal nylon flocked swabs with universal transport medium and rayon-bud swabs with a sponge reservoir of viral transport medium in the diagnosis of paediatric influenza. Esposito S, Molteni CG, Daleno C, Valzano A, Cesati L, Gualtieri L, Tagliabue C, Bosis S, Principi N, J Med Microbiol 2010 59 96 99 10.1099/jmm.0.015305-0 19815662
32. Oseltamivir-resistant A/H1N1 pandemic influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. Esposito S, Molteni CG, Colombo C, Daleno C, Dacc V, Lackenby A, Principi N, J Clin Virol 2010 48 62 65 10.1016/j.jcv.2010.02.019 20335065
33. Feigin RD, Cherry JD, Textbook of Pediatric Infectious Diseases Philadelphia, PA: W. B. Saunders Company 6 2009
34. World Health Organization, Pneumonia Vaccine Trial Investigators Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children Geneva: Department of vaccines and biologicals, World Health Organization 2001 22676626
35. Centers for Disease Control and Prevention, CDC protocol of real-time RT-PCR for swine influenza A (H1N1), 28 April 2009 revision 1 (30 April 2009) 2010 http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/ index.html
36. Towards fully automated genome-wide polymorphism screening. Livak KJ, Marmaro J, Todd JA, Nat Genet 1995 9 341 342 10.1038/ng0495-341 7795635
37. The TaqMan method for SNP genotyping. Shen GQ, Abdullah KG, Wang QK, Methods Mol Biol 2009 578 293 306 10.1007/978-1-60327-411-1-19 19768602
38. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, Coskun M, Cilli A, Yegin O, Eur Resp J 2004 23 219 223 10.1183/09031936.03. 00061703 (Pubitemid 38195506)